JCI - Citations to Treatment of murine lupus with cDNA encoding IFN-γR/Fc

Citations to this article

Treatment of murine lupus with cDNA encoding IFN-γR/Fc

Brian R. Lawson, … , Dwight H. Kono, Argyrios N. Theofilopoulos

Brian R. Lawson, … , Dwight H. Kono, Argyrios N. Theofilopoulos

Published January 15, 2000
Citation Information: J Clin Invest. 2000;106(2):207-215. https://doi.org/10.1172/JCI10167.

View: Text | PDF

Total citations by year

Year:	2023	2022	2020	2017	2016	2015	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	Total
Citations:	1	1	2	3	4	1	4	7	9	5	6	7	6	7	17	16	16	12	10	3	137

Citation information

Citations to this article (137)

Title and authors	Publication	Year
Th1/17 polarization and potential treatment by an anti-interferon-γ DNA aptamer in Hunner-type interstitial cystitis. Akiyama Y, Harada K, Miyakawa J, Kreder KJ, O'Donnell MA, Daichi M, Katoh H, Hori M, Owari K, Futami K, Ishikawa S, Ushiku T, Kume H, Homma Y, Luo Y	iScience	2023
IFN-γ, should not be ignored in SLE Liu W, Zhang S, Wang J	Frontiers in immunology	2022
Type II but Not Type I IFN Signaling Is Indispensable for TLR7-Promoted Development of Autoreactive B Cells and Systemic Autoimmunity SB Chodisetti, AJ Fike, PP Domeier, H Singh, NM Choi, C Corradetti, YI Kawasawa, TK Cooper, R Caricchio, ZS Rahman	Journal of immunology (Baltimore, Md. : 1950)	2020
Understanding the immunopathogenesis of autoimmune diseases by animal studies using gene modulation: A comprehensive review KH Lee, BS Ahn, D Cha, WW Jang, E Choi, S Park, JH Park, J Oh, DE Jung, H Park, JH Park, Y Suh, D Jin, S Lee, YH Jang, T Yoon, MK Park, Y Seong, J Pyo, S Yang, Y Kwon, H Jung, CK Lim, JB Hong, Y Park, E Choi, JI Shin, A Kronbichler	Autoimmunity Reviews	2020
Decreased ex vivo production of interferon-gamma is associated with severity and poor prognosis in patients with lupus SS Ahn, ES Park, JS Shim, SJ Ha, BS Kim, SM Jung, SW Lee, YB Park, JJ Song	Arthritis Research & Therapy	2017
Induction of Systemic Autoimmunity by a Xenobiotic Requires Endosomal TLR Trafficking and Signaling from the Late Endosome and Endolysosome but Not Type I IFN KM Pollard, GM Escalante, H Huang, KM Haraldsson, P Hultman, JM Christy, RD Pawar, JM Mayeux, R Gonzalez-Quintial, R Baccala, B Beutler, AN Theofilopoulos, DH Kono	Journal of immunology (Baltimore, Md. : 1950)	2017
Effects of Arsenic Trioxide on INF-gamma Gene Expression in MRL/lpr Mice and Human Lupus H Hu, E Chen, Y Li, X Zhu, T Zhang, X Zhu	Biological Trace Element Research	2017
IFN-γ receptor and STAT1 signaling in B cells are central to spontaneous germinal center formation and autoimmunity PP Domeier, SB Chodisetti, C Soni, SL Schell, MJ Elias, EB Wong, TK Cooper, D Kitamura, ZS Rahman	Journal of Experimental Medicine	2016
Spontaneous germinal centers and autoimmunity PP Domeier, SL Schell, ZS Rahman	Autoimmunity	2016
The Role of the Transcription Factor Ets1 in Lupus and Other Autoimmune Diseases LA Garrett-Sinha, A Kearly, AB Satterthwaite	Critical reviews in immunology	2016
Handbook of Electroporation D Miklavcic	Handbook of Electroporation	2016
Targeting Interferons in Systemic Lupus Erythematosus: Current and Future Prospects A Mathian, M Hie, F Cohen-Aubart, Z Amoura	Drugs	2015
Critical role of transmethylation in TLR signaling and systemic lupus erythematosus V Tardif, Y Manenkova, M Berger, K Hoebe, JP Zuo, C Yuan, DH Kono, AN Theofilopoulos, BR Lawson	Clinical Immunology	2013
Dubois' Lupus Erythematosus and Related Syndromes JC Crispín, GC Tsokos	Dubois' Lupus Erythematosus and Related Syndromes	2013
Aberrant B-lymphocyte responses in lupus: inherent or induced and potential therapeutic targets TE Taher, HA Muhammad, A Rahim, F Flores-Borja, Y Renaudineau, DA Isenberg, RA Mageed	European Journal of Clinical Investigation	2013
Interferon-γ and systemic autoimmunity KM Pollard, DM Cauvi, CB Toomey, KV Morris, DH Kono	Discovery medicine	2013
TLRs and IFNs: Critical Pieces of the Autoimmunity Puzzle Argyrios N. Theofilopoulos	Journal of Clinical Investigation	2012
Brenner and Rector's The Kidney C Brugnara, KU Eckardt	Brenner and Rector's The Kidney	2012
Definition of IFN-γ-related pathways critical for chemically-induced systemic autoimmunity KM Pollard, P Hultman, CB Toomey, DM Cauvi, HM Hoffman, JC Hamel, DH Kono	Journal of Autoimmunity	2012
Interferon-γ Excess Leads to Pathogenic Accumulation of Follicular Helper T Cells and Germinal Centers SK Lee, DG Silva, JL Martin, A Pratama, X Hu, PP Chang, G Walters, CG Vinuesa	Immunity	2012
Immunotherapeutic Agents for SLE A Kaul, D D’Cruz, GR Hughes	Immunotherapeutic Agents for SLE	2012
Biological Therapy in Systemic Lupus Erythematosus M Postal, LT Costallat, S Appenzeller	International Journal of Rheumatology	2012
Roles of Pro- and Anti-Inflammatory Cytokines in the Pathogenesis of SLE DL Su, ZM Lu, MN Shen, X Li, LY Sun	Journal of Biomedicine and Biotechnology	2012
Murine Models of Systemic Lupus Erythematosus D Perry, A Sang, Y Yin, YY Zheng, L Morel	Journal of Biomedicine and Biotechnology	2011
Novel Treatments for Systemic Lupus Erythematosus W Xiong, RG Lahita	Therapeutic Advances in Musculoskeletal Diseases	2011
Inflammatory Cytokines in Systemic Lupus Erythematosus K Ohl, K Tenbrock	Journal of Biomedicine and Biotechnology	2011
Interferons in Autoimmune and Inflammatory Diseases: Regulation and Roles D Choubey, KD Moudgil	Journal of Interferon & Cytokine Research	2011
Role of the MICA polymorphism in systemic lupus erythematosus K Yoshida, K Komai, K Shiozawa, A Mashida, T Horiuchi, Y Tanaka, M Nose, A Hashiramoto, S Shiozawa	Arthritis & Rheumatism	2011
Th Subset Balance in Lupus Nephritis K Miyake, M Akahoshi, H Nakashima	Journal of Biomedicine and Biotechnology	2011
Th Subset Balance in Lupus Nephritis K Miyake, M Akahoshi, H Nakashima		2011
Novel treatments for systemic lupus erythematosus W Xiong, RG Lahita	Therapeutic Advances in Musculoskeletal Diseases	2011
TH17 Cells in Health and Disease S Jiang		2011
Therapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-gamma targeting gene therapy T Hayashi	Journal of biomedicine & biotechnology	2010
Decay-accelerating factor 1 (Daf1) deficiency exacerbates xenobiotic-induced autoimmunity CB Toomey, DM Cauvi, WC Song, KM Pollard	Immunology	2010
Anticytokine therapy in systemic lupus erythematosus CS Lau, DH Yoo	Lupus	2010
Anticytokine therapy in systemic lupus erythematosus CS Lau, DH Yoo	Lupus	2010
Cutting Edge: IL-23 Receptor Deficiency Prevents the Development of Lupus Nephritis in C57BL/6– lpr/lpr Mice VC Kyttaris, Z Zhang, VK Kuchroo, M Oukka, GC Tsokos	Journal of immunology (Baltimore, Md. : 1950)	2010
The Multi-faceted Influences of Estrogen on Lymphocytes: Toward Novel Immuno-interventions Strategies for Autoimmunity Management E Karpuzoglu, M Zouali	Clinical Reviews in Allergy & Immunology	2009
Gene therapy of the rheumatic diseases: 1998 to 2008 CH Evans, SC Ghivizzani, PD Robbins	Arthritis Research & Therapy	2009
Stage dependent aberrant regulation of cytokine-STAT signaling in murine systemic lupus erythematosus MB Hale, PO Krutzik, SS Samra, JM Crane, GP Nolan	PloS one	2009
Cytokines in systemic lupus erythematosus EV Lourenço, AL Cava	Current molecular medicine	2009
Emerging Protein Biotherapeutics R Eisenberg	Emerging Protein Biotherapeutics	2009
Stage Dependent Aberrant Regulation of Cytokine-STAT Signaling in Murine Systemic Lupus Erythematosus MB Hale, PO Krutzik, SS Samra, JM Crane, GP Nolan, D Unutmaz	PloS one	2009
Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients AH Sawalha, M Jeffries, R Webb, Q Lu, G Gorelik, D Ray, J Osban, N Knowlton, K Johnson, B Richardson	Genes and Immunity	2008
Excessive Production of IFN-γ in Patients with Systemic Lupus Erythematosus and Its Contribution to Induction of B Lymphocyte Stimulator/B Cell-Activating Factor/TNF Ligand Superfamily-13B M Harigai, M Kawamoto, M Hara, T Kubota, N Kamatani, N Miyasaka	Journal of immunology (Baltimore, Md. : 1950)	2008
Therapy in Nephrology & Hypertension WL Whittier, JB Lewis, EJ Lewis	Therapy in Nephrology & Hypertension	2008
Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger BA Croker, BR Lawson, S Rutschmann, M Berger, C Eidenschenk, AL Blasius, EM Moresco, S Sovath, L Cengia, LD Shultz, AN Theofilopoulos, S Pettersson, BA Beutler	Proceedings of the National Academy of Sciences	2008
Regulatory T Cells and Clinical Application S Jiang		2008
Electroporation Protocols S Li	Electroporation Protocols	2008
Fas Expression on Antigen-Specific T Cells Has Costimulatory, Helper, and Down-Regulatory Functions In Vivo for Cytotoxic T Cell Responses but Not for T Cell-Dependent B Cell Responses I Puliaeva, R Puliaev, A Shustov, M Haas, CS Via	Journal of immunology (Baltimore, Md. : 1950)	2008
A compass that points to lupus: genetic studies on type I interferon pathway C Kyogoku, N Tsuchiya	Genes and Immunity	2007
Development of biologicals for the therapy of lupus erythematosus D Neumann, T Tschernig, D Boraschi	Expert Review of Vaccines	2007
Plasmid-based gene therapy of diabetes mellitus GJ Prud'homme, R Draghia-Akli, Q Wang	Gene Therapy	2007
Electroporation-mediated gene therapy Y Isaka, E Imai	Expert Opinion on Drug Delivery	2007
Postnatal Blocking of Interferon-.GAMMA. Function Prevented Atherosclerotic Plaque Formation in Apolipoprotein E-Knockout Mice M KOGA, H KAI, H YASUKAWA, S KATO, T YAMAMOTO, Y KAWAI, K KUSABA, Y SEKI, M KAI, K EGASHIRA, Y KATAOKA, T IMAIZUMI	Hypertension Research	2007
Characterization of Reciprocal Lmb1–4 Interval MRL- Faslpr and C57BL/6- Faslpr Congenic Mice Reveals Significant Effects from Lmb3 ML Santiago-Raber, MK Haraldsson, AN Theofilopoulos, DH Kono	Journal of immunology (Baltimore, Md. : 1950)	2007
Gene transfer of soluble transforming growth factor type II receptor by in vivo electroporation attenuates lung injury and fibrosis M Yamada, K Kuwano, T Maeyama, M Yoshimi, N Hamada, J Fukumoto, K Egashira, K Hiasa, K Takayama, Y Nakanishi	Journal of clinical pathology	2006
Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production M Kawamoto, M Harigai, M Hara, Y Kawaguchi, K Tezuka, M Tanaka, T Sugiura, Y Katsumata, C Fukasawa, H Ichida, S Higami, N Kamatani	Arthritis Research & Therapy	2006
Roles of genetic variations in signalling/immunoregulatory molecules in susceptibility to systemic lupus erythematosus M Akahoshi, H Nakashima, T Shirakawa	Seminars in Immunology	2006
Systemic Lupus Erythematosus M Petri	JCR: Journal of Clinical Rheumatology	2006
IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice M Muraoka, H Hasegawa, M Kohno, A Inoue, T Miyazaki, M Terada, M Nose, M Yasukawa	Arthritis & Rheumatism	2006
Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice M Kumar, Y Hunag, Y Glinka, GJ Prud'Homme, Q Wang	Gene Therapy	2006
New therapies for systemic lupus erythematosus: has the future arrived? A Kaul, D D'Cruz, GR Hughes	Future Rheumatology	2006
Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis L Bao, I Osawe, M Haas, RJ Quigg	Journal of immunology (Baltimore, Md. : 1950)	2005
Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1) S Shimizu, N Sugiyama, K Masutani, A Sadanaga, Y Miyazaki, Y Inoue, M Akahoshi, R Katafuchi, H Hirakata, M Harada, S Hamano, H Nakashima, H Yoshida	Journal of immunology (Baltimore, Md. : 1950)	2005
Autoimmune alterations induced by the New Zealand Black Lbw2 locus in BWF1 mice Maria K Haraldsson, Nathanial G dela Paz, Jason G Kuan, Gary S Gilkeson, Argyrios N Theofilopoulos, Dwight H Kono	Journal of immunology (Baltimore, Md. : 1950)	2005
C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist L Bao, I Osawe, T Puri, JD Lambris, M Haas, RJ Quigg	European Journal of Immunology	2005
IFN-α Induces Early Lethal Lupus in Preautoimmune (New Zealand Black × New Zealand White)F 1 but Not in BALB/c Mice A Mathian, A Weinberg, M Gallegos, J Banchereau, S Koutouzov	Journal of immunology (Baltimore, Md. : 1950)	2005
DNA vaccination with an insulin construct and a chimeric protein binding to both CTLA4 and CD40 ameliorates type 1 diabetes in NOD mice Y Chang, S Yap, X Ge, J Piganelli, S Bertera, N Giannokakis, C Mathews, G Prud'homme, M Trucco	Gene Therapy	2005
Anti-Vascular Endothelial Growth Factor Gene Therapy Attenuates Lung Injury and Fibrosis in Mice N Hamada, K Kuwano, M Yamada, N Hagimoto, K Hiasa, K Egashira, N Nakashima, T Maeyama, M Yoshimi, Y Nakanishi	Journal of immunology (Baltimore, Md. : 1950)	2005
Interferon pathway activation in systemic lupus erythematosus MK Crow	Current Rheumatology Reports	2005
Interferons as pathogenic effectors in autoimmunity R Baccala, DH Kono, AN Theofilopoulos	Immunological Reviews	2005
Amelioration of SLE-like manifestations in (NZBxNZW)F1 mice following treatment with a peptide based on the complementarity determining region 1 of an autoantibody is associated with a down-regulation of apoptosis and of the pro-apoptotic factor JNK kinase MJ Rapoport, A Sharabi, D Aharoni, O Bloch, H Zinger, M Dayan, E Mozes	Clinical Immunology	2005
Defects in the interferon-gamma and interleukin-12 pathways SD Rosenzweig, SM Holland	Immunological Reviews	2005
Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice A Sadanaga, H Nakashima, K Masutani, K Miyake, S Shimizu, T Igawa, N Sugiyama, H Niiro, H Hirakata, M Harada	Arthritis & Rheumatism	2005
Sustained low-level expression of interferon-γ promotes tumor development: potential insights in tumor prevention and tumor immunotherapy YF He, XH Wang, GM Zhang, HT Chen, H Zhang, ZH Feng	Cancer Immunology, Immunotherapy	2005
Electroporation for targeted gene transfer LC Heller, K Ugen, R Heller	Expert Opinion on Drug Delivery	2005
Immunothérapies du lupus systémique : innovations et perspectives J Sibilia, C Sordet	Revue du Rhumatisme	2005
Molecular Autoimmunity M Zouali		2005
Sustained low-level expression of interferon-gamma promotes tumor development: potential insights in tumor prevention and tumor immunotherapy. He YF, Wang XH, Zhang GM, Chen HT, Zhang H, Feng ZH	Cancer Immunology, Immunotherapy	2005
Type I IFN protects against murine lupus JD Hron, SL Peng	Journal of immunology (Baltimore, Md. : 1950)	2004
Aberration of CCR7+ CD8+ memory T cells from patients with systemic lupus erythematosus: an inducer of T helper type 2 bias of CD4+ T cells Y Sen, H Chunsong, H Baojun, Z Linjie, L Qun, J San, Z Qiuping, L Junyan, X Zhang, T Jinquan	Immunology	2004
Therapeutic Antibody Gene Transfer: An Active Approach to Passive Immunity JM Bakker, WK Bleeker, PW Parren	Molecular Therapy	2004
Genomic absence of the gene encoding T cell receptor V?7.2 is linked to the presence of autoantibodies in Sj�gren's syndrome SJ Manavalan, JR Valiando, WH Reeves, FC Arnett, A Necker, R Simantov, R Lyons, M Satoh, DN Posnett	Arthritis & Rheumatism	2004
Perspectives for Gene Therapy in Renal Diseases E IMAI, Y ISAKA	Internal Medicine	2004
Deficiency of the cyclin kinase inhibitor p21(WAF-1/CIP-1) promotes apoptosis of activated/memory T cells and inhibits spontaneous systemic autoimmunity BR Lawson, R Baccala, J Song, M Croft, DH Kono, AN Theofilopoulos	Journal of Experimental Medicine	2004
Gene therapy for autoimmune diseases: quo vadis? Y Chernajovsky, DJ Gould, OL Podhajcer	Nature Reviews Immunology	2004
Interferon-?? in systemic lupus erythematosus MK Crow, KA Kirou	Current Opinion in Rheumatology	2004
Analyses of serum levels of type 1, type 2 and type 3 cytokines reveal multiple abnormalities in lupus-prone (NZB x NZW) F1 mice DA de Albuquerque, FM Ebling, DW Lienesch, RR Singh, BH Hahn	APLAR Journal of Rheumatology	2004
A Novel Method to Assay Proteins in Blood Plasma after Intravenous Injection of Plasmid DNA H Hanawa, R Watanabe, M Hayashi, T Yoshida, S Abe, S Komura, H Liu, R Elnaggar, H Chang, Y Okura, K Kato, M Kodama, H Maruyama, J Miyazaki, Y Aizawa	The Tohoku Journal of Experimental Medicine	2004
Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice I Inoshima, K Kuwano, N Hamada, N Hagimoto, M Yoshimi, T Maeyama, A Takeshita, S Kitamoto, K Egashira, N Hara	American journal of physiology. Lung cellular and molecular physiology	2004
Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus KA Kirou, C Lee, S George, K Louca, IG Papagiannis, MG Peterson, N Ly, RN Woodward, KE Fry, AY Lau, JG Prentice, JG Wohlgemuth, MK Crow	Arthritis & Rheumatism	2004
Therapeutic strategies for refractory systemic lupus erythematosus PI Sidiropoulos, GK Bertsias, HD Kritikos, DT Boumpas	Drug Discovery Today: Therapeutic Strategies	2004
Gene therapy in systemic lupus erythematosus VC Kyttaris, YT Juang, GC Tsokos	Lupus	2004
Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients PI Sidiropoulos, DT Boumpas	Lupus	2004
Decreased Expression of the Ets Family Transcription Factor Fli-1 Markedly Prolongs Survival and Significantly Reduces Renal Disease in MRL/ lpr Mice XK Zhang, S Gallant, I Molano, OM Moussa, P Ruiz, DD Spyropoulos, DK Watson, G Gilkeson	Journal of immunology (Baltimore, Md. : 1950)	2004
Enhanced expression of interferon-inducible protein 10 associated with Th1 profiles of chemokine receptor in autoimmune pulmonary inflammation of MRL/lpr mice F Shiozawa, T Kasama, N Yajima, T Odai, T Isozaki, M Matsunawa, Y Yoda, M Negishi, H Ide, M Adachi	Arthritis Research & Therapy	2003
Modulation of renal glomerular disease using remote delivery of adenoviral-encoded solubletype II TGF-? receptor fusion molecule YS Haviv, K Takayama, PA Nagi, A Tousson, W Cook, M Wang, JT Lam, S Naito, X Lei, DE Carey, DT Curiel	The Journal of Gene Medicine	2003
Differential effects of interleukin-4 in peptide induced autoimmunity B Deocharan, P Marambio, M Edelman, C Putterman	Clinical Immunology	2003
Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice ML Santiago-Raber, R Baccala, KM Haraldsson, D Choubey, TA Stewart, DH Kono, AN Theofilopoulos	Journal of Experimental Medicine	2003
Microarray analysis of gene expression in lupus MK Crow, J Wohlgemuth	Arthritis Research & Therapy	2003
A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis DT Boumpas, R Furie, S Manzi, GG Illei, DJ Wallace, JE Balow, A Vaishnaw	Arthritis & Rheumatism	2003
IL-12 Gene Therapy Using an Electrically Mediated Nonviral Approach Reduces Metastatic Growth of Melanoma ML Lucas, R Heller	DNA and Cell Biology	2003
Using Single-Gene Deletions to Identify Checkpoints in the Progression of Systemic Autoimmunity KM Pollard, P Hultman, DH Kono	Annals of the New York Academy of Sciences	2003
Links Between Type I Interferons and the Genetic Basis of Disease in Mouse Lupus TN JØrgensen, MR Gubbels, BL Kotzin	Autoimmunity	2003
Inhibition of Lupus by Genetic Alteration of the Interferon-α/β Receptor DH Kono, R Baccala, AN Theofilopoulos	Autoimmunity	2003
Microarray Analysis of Interferon-regulated Genes in SLE MK Crow, KA Kirou, J Wohlgemuth	Autoimmunity	2003
Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB ×NZWF1 mice K Hasegawa, T Hayashi	Lupus	2003
Intramuscular gene transfer of soluble B7.1/IgG1 fusion cDNA induces potent antitumor immunity as an adjuvant for DNA vaccination ZF Zhou, Y Peretz, Y Chang, DS Miao, X Li, GJ Prud'homme	Cancer Gene Therapy	2003
Immunopathology and the gene therapy of lupus RA Mageed, GJ Prud'homme	Gene Therapy	2003
Cytokines and Chemokines in Autoimmune Disease P Santamaria		2003
IL-12 Deficiency in MRL- Faslpr Mice Delays Nephritis and Intrarenal IFN-γ Expression, and Diminishes Systemic Pathology E Kikawada, DM Lenda, VR Kelley	Journal of immunology (Baltimore, Md. : 1950)	2003
Essential role of monocyte chemoattractant protein-1 in development of restenotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits E Mori, K Komori, T Yamaoka, M Tanii, C Kataoka, A Takeshita, M Usui, K Egashira, K Sugimachi	Circulation	2002
Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease Y Sun, HM Chen, SK Subudhi, J Chen, R Koka, L Chen, YX Fu	Nature Medicine	2002
Immunoinhibitory DNA Vaccine Protects Against Autoimmune Diabetes Through cDNA Encoding a Selective CTLA-4 (CD152) Ligand GJ Prud'homme, Y Chang, X Li	Human Gene Therapy	2002
Autocrine production of IFN-gamma by macrophages controls their recruitment to kidney and the development of glomerulonephritis in MRL/lpr mice CE Carvalho-Pinto, MI García, M Mellado, JM Rodríguez-Frade, J Martín-Caballero, J Flores, C Martínez-A, D Balomenos	Journal of immunology (Baltimore, Md. : 1950)	2002
Direct Transfer of p65 into T Lymphocytes from Systemic Lupus Erythematosus Patients Leads to Increased Levels of Interleukin-2 Promoter Activity TM Herndon, YT Juang, EE Solomou, SW Rothwell, MF Gourley, GC Tsokos	Clinical Immunology	2002
The Potential for Gene Therapy in the Treatment of Autoimmune Disease IH Tarner, CG Fathman	Clinical Immunology	2002
Adoptive cellular gene therapy of autoimmune disease AJ Slavin, IH Tarner, A Nakajima, I Urbanek-Ruiz, J McBride, CH Contag, CG Fathman	Autoimmunity Reviews	2002
Gene electrotransfer: Potential for gene therapy of renal diseases E Imai, Y Isaka	Kidney International	2002
Therapy of systemic lupus erythematosus: a look into the future JS Smolen	Arthritis research	2002
IL-10 regulates murine lupus Z Yin, G Bahtiyar, N Zhang, L Liu, P Zhu, ME Robert, J McNiff, MP Madaio, J Craft	Journal of immunology (Baltimore, Md. : 1950)	2002
Promotion of Lupus in NZB×NZWF1 Mice by Plasmids Encoding Interferon (IFN)-γ But Not by Those Encoding Interleukin (IL)-4 K Hasegawa, T Hayashi, K Maeda	Journal of Comparative Pathology	2002
Deletion of p21 (WAF-1/Cip1) Does Not Induce Systemic Autoimmunity in Female BXSB Mice BR Lawson, DH Kono, AN Theofilopoulos	Journal of immunology (Baltimore, Md. : 1950)	2002
Anticytokine gene therapy of autoimmune diseases GJ Prud’homme, BR Lawson, AN Theofilopoulos	Expert Opinion on Biological Therapy	2001
The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity AN Theofilopoulos, S Koundouris, DH Kono, BR Lawson	Arthritis research	2001
Gene Therapy for Tolerance and Autoimmunity: Soon To Be Fulfilled Promises? M El-Amine, ME Melo, DW Scott	Clinical Immunology	2001
Immunotherapeutic gene transfer into muscle GJ Prud'homme, BR Lawson, Y Chang, AN Theofilopoulos	Trends in Immunology	2001
Gene therapy in autoimmune disease IH Tarner, CG Fathman	Current Opinion in Immunology	2001
Evidence for an Interferon-Inducible Gene, Ifi202, in the Susceptibility to Systemic Lupus SJ Rozzo, JD Allard, D Choubey, TJ Vyse, S Izui, G Peltz, BL Kotzin	Immunity	2001
Reduction of Serum Interferon (IFN)-γ Concentration and Lupus Development in NZBxNZWF1Mice by Lactic Dehydrogenase Virus Infection T Hayashi, K Hasegawa, A Ohta, K Maeda	Journal of Comparative Pathology	2001
Interferon-γ polymorphisms in systemic lupus erythematosus JY Lee, D Goldman, LM Piliero, M Petri, KE Sullivan	Genes and Immunity	2001
The Role of αβ + T Cells and Homeostatic T Cell Proliferation in Y-Chromosome-Associated Murine Lupus BR Lawson, SI Koundouris, M Barnhouse, W Dummer, R Baccala, DH Kono, AN Theofilopoulos	Journal of immunology (Baltimore, Md. : 1950)	2001
Role of Cyclin Kinase Inhibitor p21 in Systemic Autoimmunity ML Santiago-Raber, BR Lawson, W Dummer, M Barnhouse, S Koundouris, CB Wilson, DH Kono, AN Theofilopoulos	Journal of immunology (Baltimore, Md. : 1950)	2001
Gene therapy in the treatment of autoimmune diseases GC Tsokos, GT Nepom	Journal of Clinical Investigation	2000
Uveitis CE Egwuagu, JA Smith	Expert Opinion on Therapeutic Targets	2000
Treatment of murine lupus with cDNA encoding IFN-?R/Fc C Smythe	Arthritis Research & Therapy	2000

Advertisement